Filed: 5/14/2026ACC: 0001440771-26-000002
📋 What this filing means
STONEPINE CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 72 equity positions with a total reported market value of $249.72M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
72
Positions
$249.72M
Total AUM (reported)
86.54M
Total Shares
Allocation by class
STATE STREET SPD$102.18M40.9%
COM$73.50M29.4%
COM NEW$64.49M25.8%
SPONSORED ADS$3.73M1.5%
SHS NEW$3.57M1.4%
SHS$812.2K0.3%
COM SHS$666.5K0.3%
Portfolio Concentration
Top 3$136.72M54.7%
4–10$50.33M20.2%
11–25$33.81M13.5%
Rest$28.87M11.6%
Top 3 weight
54.7%
Top 10 weight
74.9%
Voting Authority Distribution
Total shares with voting rights: 86.54M
Sole
Full voting authority
86.54M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole72
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings72
Rows:
SPDR SERIES TRUST
SOLEShares800K
TypeSH
Market value$102.18M
40.92%
Sole
800K
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares3.30M
TypeSH
Market value$17.50M
7.01%
Sole
3.30M
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares1.89M
TypeSH
Market value$17.03M
6.82%
Sole
1.89M
Shared
0.00
None
0.00
TENAX THERAPEUTICS INC
SOLEShares975.20K
TypeSH
Market value$15.59M
6.24%
Sole
975.20K
Shared
0.00
None
0.00
EVOLUS INC
SOLEShares2.18M
TypeSH
Market value$8.96M
3.59%
Sole
2.18M
Shared
0.00
None
0.00
CAMP4 THERAPEUTICS CORP
SOLEShares1.39M
TypeSH
Market value$6.13M
2.45%
Sole
1.39M
Shared
0.00
None
0.00
NEKTAR THERAPEUTICS
SOLEShares85K
TypeSH
Market value$6.12M
2.45%
Sole
85K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares100K
TypeSH
Market value$5.27M
2.11%
Sole
100K
Shared
0.00
None
0.00
ZEVRA THERAPEUTICS INC
SOLEShares480K
TypeSH
Market value$4.47M
1.79%
Sole
480K
Shared
0.00
None
0.00
ABEONA THERAPEUTICS INC
SOLEShares846.59K
TypeSH
Market value$3.79M
1.52%
Sole
846.59K
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares383.46K
TypeSH
Market value$3.60M
1.44%
Sole
383.46K
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares56K
TypeSH
Market value$3.18M
1.27%
Sole
56K
Shared
0.00
None
0.00
KAZIA THERAPEUTICS LTD
SOLEShares345.18K
TypeSH
Market value$2.57M
1.03%
Sole
345.18K
Shared
0.00
None
0.00
AN2 THERAPEUTICS INC
SOLEShares713.85K
TypeSH
Market value$2.44M
0.98%
Sole
713.85K
Shared
0.00
None
0.00
ALEXANDRIA REAL ESTATE EQ IN
SOLEShares50K
TypeSH
Market value$2.32M
0.93%
Sole
50K
Shared
0.00
None
0.00
ACADIA PHARMACEUTICALS INC
SOLEShares100K
TypeSH
Market value$2.23M
0.89%
Sole
100K
Shared
0.00
None
0.00
SOL-GEL TECHNOLOGIES LTD
SOLEShares27.78K
TypeSH
Market value$2.20M
0.88%
Sole
27.78K
Shared
0.00
None
0.00
XOMA ROYALTY CORPORATION
SOLEShares69.50K
TypeSH
Market value$2.18M
0.87%
Sole
69.50K
Shared
0.00
None
0.00
AYTU BIOPHARMA INC
SOLEShares792.29K
TypeSH
Market value$2.16M
0.87%
Sole
792.29K
Shared
0.00
None
0.00
CURIS INC
SOLEShares3.73M
TypeSH
Market value$2.04M
0.82%
Sole
3.73M
Shared
0.00
None
0.00
HERON THERAPEUTICS INC
SOLEShares2.40M
TypeSH
Market value$1.92M
0.77%
Sole
2.40M
Shared
0.00
None
0.00
CYTOMX THERAPEUTICS INC.
SOLEShares400K
TypeSH
Market value$1.88M
0.75%
Sole
400K
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDINGS INC
SOLEShares320.03K
TypeSH
Market value$1.86M
0.74%
Sole
320.03K
Shared
0.00
None
0.00
TELA BIO INC
SOLEShares2.62M
TypeSH
Market value$1.62M
0.65%
Sole
2.62M
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares957.20K
TypeSH
Market value$1.61M
0.64%
Sole
957.20K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR SERIES TRUSTSOLE | STATE STREET SPD | 800K | SH | $102.18M 40.92% | 800K | 0.00 | 0.00 |
VERASTEM INCSOLE | COM NEW | 3.30M | SH | $17.50M 7.01% | 3.30M | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 1.89M | SH | $17.03M 6.82% | 1.89M | 0.00 | 0.00 |
TENAX THERAPEUTICS INCSOLE | COM NEW | 975.20K | SH | $15.59M 6.24% | 975.20K | 0.00 | 0.00 |
EVOLUS INCSOLE | COM | 2.18M | SH | $8.96M 3.59% | 2.18M | 0.00 | 0.00 |
CAMP4 THERAPEUTICS CORPSOLE | COM | 1.39M | SH | $6.13M 2.45% | 1.39M | 0.00 | 0.00 |
NEKTAR THERAPEUTICSSOLE | COM NEW | 85K | SH | $6.12M 2.45% | 85K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 100K | SH | $5.27M 2.11% | 100K | 0.00 | 0.00 |
ZEVRA THERAPEUTICS INCSOLE | COM NEW | 480K | SH | $4.47M 1.79% | 480K | 0.00 | 0.00 |
ABEONA THERAPEUTICS INCSOLE | COM NEW | 846.59K | SH | $3.79M 1.52% | 846.59K | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 383.46K | SH | $3.60M 1.44% | 383.46K | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 56K | SH | $3.18M 1.27% | 56K | 0.00 | 0.00 |
KAZIA THERAPEUTICS LTDSOLE | SPONSORED ADS | 345.18K | SH | $2.57M 1.03% | 345.18K | 0.00 | 0.00 |
AN2 THERAPEUTICS INCSOLE | COM | 713.85K | SH | $2.44M 0.98% | 713.85K | 0.00 | 0.00 |
ALEXANDRIA REAL ESTATE EQ INSOLE | COM | 50K | SH | $2.32M 0.93% | 50K | 0.00 | 0.00 |
ACADIA PHARMACEUTICALS INCSOLE | COM | 100K | SH | $2.23M 0.89% | 100K | 0.00 | 0.00 |
SOL-GEL TECHNOLOGIES LTDSOLE | SHS NEW | 27.78K | SH | $2.20M 0.88% | 27.78K | 0.00 | 0.00 |
XOMA ROYALTY CORPORATIONSOLE | COM NEW | 69.50K | SH | $2.18M 0.87% | 69.50K | 0.00 | 0.00 |
AYTU BIOPHARMA INCSOLE | COM | 792.29K | SH | $2.16M 0.87% | 792.29K | 0.00 | 0.00 |
CURIS INCSOLE | COM | 3.73M | SH | $2.04M 0.82% | 3.73M | 0.00 | 0.00 |
HERON THERAPEUTICS INCSOLE | COM | 2.40M | SH | $1.92M 0.77% | 2.40M | 0.00 | 0.00 |
CYTOMX THERAPEUTICS INC.SOLE | COM | 400K | SH | $1.88M 0.75% | 400K | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 320.03K | SH | $1.86M 0.74% | 320.03K | 0.00 | 0.00 |
TELA BIO INCSOLE | COM | 2.62M | SH | $1.62M 0.65% | 2.62M | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 957.20K | SH | $1.61M 0.64% | 957.20K | 0.00 | 0.00 |
Page 1 of 3